Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC.AIG · Entity 3083 | Director | April 01, 2024 | April 03, 2024 |
| AVON PRODUCTS INCAVP · Entity 152510 | Director | May 16, 2019 | May 20, 2019 |
| CVS HEALTH CorpCVS · Entity 2884 | Director | December 22, 2006 | December 27, 2006 |
| PFIZER INCPFE · Entity 2863 | Director | April 23, 2020 | April 24, 2020 |
| Viatris IncVTRS · Entity 3277 | Director | March 06, 2026 | March 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN INTERNATIONAL GROUP, INC.
Report date April 01, 2024 · Filed April 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 44,385 |
Reported balance
After 2024-04-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-04-01 · Grant · Acquired 204 · Balance 44,385 F1: This award represents dividend equivalent rights in the form of deferred stock units ("DSUs") that are related to the DSUs previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan"), the AIG 2013 Omnibus Incentive Plan (the "2013 Plan") and the AIG 2021 Omnibus Incentive Plan (the "2021 Plan") as compensation for service as a non-employee director. Under such plans and the related award agreements, these DSUs -- along with the underlying previously awarded DSUs -- will be settled in shares of AIG common stock on a 1-to-1 basis on the last trading day of the month in which the director's service on the Board of Directors ends, unless the director has elected to defer the vesting date. F2: Reflects DSUs previously granted pursuant to the 2010 Plan, the 2013 Plan and the 2021 Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: This award represents dividend equivalent rights in the form of deferred stock units ("DSUs") that are related to the DSUs previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan"), the AIG 2013 Omnibus Incentive Plan (the "2013 Plan") and the AIG 2021 Omnibus Incentive Plan (the "2021 Plan") as compensation for service as a non-employee director. Under such plans and the related award agreements, these DSUs -- along with the underlying previously awarded DSUs -- will be settled in shares of AIG common stock on a 1-to-1 basis on the last trading day of the month in which the director's service on the Board of Directors ends, unless the director has elected to defer the vesting date.
F2: Reflects DSUs previously granted pursuant to the 2010 Plan, the 2013 Plan and the 2021 Plan.
AVON PRODUCTS INC
Report date May 16, 2019 · Filed May 20, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 36,624 |
Reported balance
After 2019-05-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-05-16 · Grant · Acquired 36,624 · Balance 36,624 F1: Restricted stock units granted as part of each director's annual retainer under the Avon Products, Inc. Compensation Plan for Non-Employee Directors. F2: Units correspond 1-for-1 with common stock. F3: 100% of the restricted stock units vest on the date of the next annual meeting of shareholders and will settle when the director ceases to serve on the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units granted as part of each director's annual retainer under the Avon Products, Inc. Compensation Plan for Non-Employee Directors.
F2: Units correspond 1-for-1 with common stock.
F3: 100% of the restricted stock units vest on the date of the next annual meeting of shareholders and will settle when the director ceases to serve on the Board of Directors.
CVS HEALTH Corp
Report date December 22, 2006 · Filed December 27, 2006
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share CreditsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 42,200 |
Reported balance
After 2006-12-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2006-12-22 · Grant · Acquired 32 · Balance 42,200 F1: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2: Consists of Deferred Stock Compensation payable pursuant to Insider's election. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.
F2: Consists of Deferred Stock Compensation payable pursuant to Insider's election.
PFIZER INC
Report date April 23, 2020 · Filed April 24, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 138,711.391 |
Reported balance
After 2020-04-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-04-23 · Grant · Acquired 5,246.661 · Balance 138,711.391 F1: Each unit represents one phantom share of common stock. F2: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
F3: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.
Viatris Inc
Report date March 06, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 110,869 |
Reported balance
After 2026-03-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-06 · Exercise / conversion · Acquired 23,660 · Balance 110,869 F1: On May 6, 2022, Viatris Inc. filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount includes 6,867 shares of common stock as the result of the automatic reinvestment of dividends received on shares of issuer common stock pursuant to a broker-sponsored dividend reinvestment plan between September 2023 and December 2025 in transactions exempt from Section 16 under Rule 16a-11. |
| Common StockSEC Table I · non-derivative | Direct | 112,044 |
Reported balance
After 2026-03-06 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-06 · Exercise / conversion · Acquired 1,175 · Balance 112,044 F2: Fractional shares have been rounded up in connection with the settlement described in footnote 4 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-06 · Exercise / conversion · Disposed 23,660 · Balance 0 F3: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 15,890 |
Reported balance
After 2026-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-06 · Grant · Acquired 15,890 · Balance 15,890 F5: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-06 · Exercise / conversion · Disposed 1,174.4921 · Balance 0 F4: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 6, 2022, Viatris Inc. filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount includes 6,867 shares of common stock as the result of the automatic reinvestment of dividends received on shares of issuer common stock pursuant to a broker-sponsored dividend reinvestment plan between September 2023 and December 2025 in transactions exempt from Section 16 under Rule 16a-11.
F2: Fractional shares have been rounded up in connection with the settlement described in footnote 4 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F3: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.
F4: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
F5: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 27, 2003 Filed Jul 1, 2003 13:41 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 235 | $35.00 Strike: $0.00 | $8,225.00 |
DisclosureSEC source: 0000078003-03-000114 · cor362.xml · derivative · entry 1 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,008 Underlying: Common Stock · 235 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation that is settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation that is settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.